市場調査レポート

商品コード

1690000

動物用ワクチンの市場規模、シェア、成長分析：タイプ別、疾患別、技術別、投与経路別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Veterinary Vaccines Market Size, Share, and Growth Analysis, By Type, By Disease, By Technology, By Route Of Administration, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年03月22日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

動物用ワクチンの世界市場規模は2023年に86億米ドルと評価され、2024年の92億1,000万米ドルから2032年には159億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.1％で成長する見通しです。

世界の動物用ワクチン市場は、動物の健康に対する意識の高まりと、肉、牛乳、卵などの動物由来製品に対する需要の高まりに後押しされ、力強い成長を遂げています。人獣共通感染症の増加により、予防措置の必要性が強調され、食糧安全保障の重要な役割がさらに浮き彫りになっています。畜産人口の増加は、食品の安全性と持続可能性の重視の高まりとともに、市場拡大の原動力となっています。ワクチンの有効性と安全性における革新は、獣医師やペットの飼い主の間で支持を集めています。さらに、業界大手による研究開発への多額の投資と、動物疾病の予防と根絶を目標とする発展途上国における政府の取り組みが相まって、市場の成長を加速させています。動物疾病の有病率の上昇と、家禽を中心とする畜産部門の拡大は、市場のダイナミクスに大きく寄与しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Zoetis, Inc.（US）
Merck & Co, Inc.（US）
Boehringer Ingelheim International GmbH（Germany）
Elanco Animal Health（US）
Virbac（France）
Hester Biosciences Limited（India）
Neogen Corporation（US）
HIPRA（Spain）
Biogenesis Bago（Argentina）
Tianjin Ringpu Bio-Technology Co Ltd.（China）
China Animal Husbandry Group（China）
Jinyu Bio-technology（China）
Vaxxinova International BV（Netherlands）
Endovac Animal Health（US）
Brilliant Bio Pharma（India）
Aptimmune（US）
Indian Immunologicals Ltd.（India）
Torigen Pharmaceuticals, Inc.（US）
VEROVACCiNES GmbH（Germany）
Intas Pharmaceuticals（India）
Ourofino Animal Health（Brazil）
Biovac（Israel）
Laboratoire LCV（France）

結論と提言

Product Code: SQMIG35I2239

Global Veterinary Vaccines Market size was valued at USD 8.6 billion in 2023 and is poised to grow from USD 9.21 billion in 2024 to USD 15.94 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global veterinary vaccines market is experiencing robust growth, fueled by heightened awareness of animal health and rising demand for animal-derived products like meat, milk, and eggs. The increasing incidence of zoonotic diseases has underscored the necessity of preventative measures, further highlighting the critical role of food security. A growing livestock population, alongside heightened emphasis on food safety and sustainability, drives market expansion. Innovations in vaccine efficacy and safety are gaining traction among veterinarians and pet owners. Additionally, significant investments from industry leaders in research and development, combined with government initiatives in developing countries targeting the prevention and eradication of animal diseases, are accelerating market growth. The rising prevalence of animal diseases and expanding livestock sectors, particularly poultry, contribute significantly to market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segments Analysis

Global Veterinary Vaccines Market is segmented by Type, Disease, Technology, Route Of Administration, End User and region. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Veterinary Vaccines. Based on Disease, the market is segmented into Livestock Diseases, Porcine Diseases, Poultry Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Veterinary Diseases. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccine Technologies. Based on Route Of Administration, the market is segmented into Subcutaneous Route of Administration, Intramuscular Route of Administration, Oral Route of Administration, Intranasal/Spray Route of Administration, Intraocular Route of Administration and Other Routes of Administration. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Vaccines Market

The Global Veterinary Vaccines market is significantly driven by the rise in zoonotic diseases, which are illnesses that can be transmitted from animals to humans. The increasing prevalence of diseases such as rabies, avian influenza, and swine flu has led to a heightened demand for veterinary vaccines. By vaccinating domestic animals against these diseases, the risk of transmission to humans is mitigated, thereby enhancing public health and preventing potential outbreaks. Furthermore, global population growth and the shifting dietary preferences towards increased animal protein consumption, particularly in developing nations, have escalated the demand for livestock. This surge in interest and concern for animal health has resulted in a substantial expansion of the veterinary vaccines market.

Restraints in the Global Veterinary Vaccines Market

The global veterinary vaccines market faces significant constraints due to the intricate and prolonged process of developing and producing new vaccines, which involves extensive research, clinical trials, and regulatory approvals. The high costs associated with both the development and manufacturing of vaccines can render them unaffordable for many farmers and pet owners, particularly in resource-limited areas. Additionally, the expenses involved in ensuring proper storage and transportation under required conditions further increase the overall costs of vaccination. These financial barriers can hinder the widespread adoption of veterinary vaccines and inhibit market growth, especially in developing regions.

Market Trends of the Global Veterinary Vaccines Market

A significant trend in the Global Veterinary Vaccines market is the rising adoption of recombinant vaccines, leveraging advanced biotechnological methods for heightened efficacy and targeted protection against specific pathogens. These vaccines, designed as hybrids, not only enhance immunogenicity but also reduce the likelihood of adverse reactions, making them increasingly favored by veterinarians and pet owners alike. This shift aligns with a broader trend toward personalized medicine in veterinary care, as stakeholders seek innovative solutions that deliver improved health outcomes for animals. As awareness of these benefits grows, the demand for recombinant vaccines is expected to drive market expansion in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Veterinary Vaccines Market Size by Type & CAGR (2025-2032)

Market Overview
Livestock Vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
Porcine Vaccines
Poultry Vaccines
Companion Animal Vaccines
- Canine Vaccines
- Feline Vaccines
Aquaculture Vaccines
Other Veterinary Vaccines

Global Veterinary Vaccines Market Size by Disease & CAGR (2025-2032)

Market Overview
Livestock Diseases
- Bovine Diseases
- Small Ruminant Diseases
Porcine Diseases
Poultry Diseases
Companion Animal Diseases
- Canine Diseases
- Feline Diseases
Aquaculture Diseases
Other Veterinary Diseases

Global Veterinary Vaccines Market Size by Technology & CAGR (2025-2032)

Market Overview
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccine Technologies

Global Veterinary Vaccines Market Size by Route Of Administration & CAGR (2025-2032)

Market Overview
Subcutaneous Route of Administration
Intramuscular Route of Administration
Oral Route of Administration
Intranasal/Spray Route of Administration
Intraocular Route of Administration
Other Routes of Administration

Global Veterinary Vaccines Market Size by End User & CAGR (2025-2032)

Market Overview
Veterinary Hospitals
Veterinary Clinics
Other End Users

Global Veterinary Vaccines Market Size & CAGR (2025-2032)

North America (Type, Disease, Technology, Route Of Administration, End User)
- US
- Canada
Europe (Type, Disease, Technology, Route Of Administration, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Disease, Technology, Route Of Administration, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Disease, Technology, Route Of Administration, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Disease, Technology, Route Of Administration, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Zoetis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hester Biosciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HIPRA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tianjin Ringpu Bio-Technology Co Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinyu Bio-technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxxinova International BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endovac Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brilliant Bio Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptimmune (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Torigen Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VEROVACCiNES GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intas Pharmaceuticals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ourofino Animal Health (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovac (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoire LCV (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

動物用ワクチンの市場規模、シェア、成長分析：タイプ別、疾患別、技術別、投与経路別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Veterinary Vaccines Market Size, Share, and Growth Analysis, By Type, By Disease, By Technology, By Route Of Administration, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

動物用ワクチン市場規模：タイプ別& CAGR（2025-2032）

動物用ワクチン市場規模：疾患別& CAGR（2025-2032）

動物用ワクチン市場規模：技術別& CAGR（2025-2032）

動物用ワクチン市場規模：投与経路別& CAGR（2025-2032）

動物用ワクチン市場規模：エンドユーザー別& CAGR（2025-2032）

動物用ワクチン市場規模：地域別& CAGR（2025-2032）